SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001516551-23-000073
Filing Date
2023-09-07
Accepted
2023-09-07 13:15:02
Documents
17
Period of Report
2023-09-06
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K skye-20230906.htm   iXBRL 8-K 35577
2 EX-3.1 certificateofchangerever.htm EX-3.1 2854
3 EX-3.2 certificateofcorrection-.htm EX-3.2 2242
4 EX-99.1 a230906_skyereversesplitfi.htm EX-99.1 8663
8 certificateofchangerever001.jpg GRAPHIC 215815
9 certificateofcorrection-001.jpg GRAPHIC 174338
  Complete submission text file 0001516551-23-000073.txt   716865

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skye-20230906.xsd EX-101.SCH 1923
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skye-20230906_lab.xml EX-101.LAB 23083
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skye-20230906_pre.xml EX-101.PRE 12063
11 EXTRACTED XBRL INSTANCE DOCUMENT skye-20230906_htm.xml XML 2637
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55136 | Film No.: 231241728
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences